skip to Main Content
 

Three Quick Facts: Clarkson, Hikma Pharmaceuticals and Polymetal

*

Clarkson [LSE: CKN]

We have slim pickings in terms of corporate news this morning but Clarkson have issued full year results. The company is a world leading in shipbroking, which is the link between ship owners and the companies that charter them. After a period of overcapacity, the market does seem to be improving although the numbers are very much ‘steady as she goes’. Earnings per share came in 11% higher, bang on the consensus forecast whilst the dividend is up 12% – marking 15 years of consecutive dividend growth.


Hikma Pharmaceuticals [LSE: HIK]

The pharmaceuticals company Hikma has published a note this morning as it continues in a battle to get a generic version of a competitor’s drug approved in the US market. It took the Food & Drug Administration (FDA) to a dispute resolution panel over a recent finding, but the committee ruled in favour for the FDA. It’s not the end of the road for the project but means more testing costs will be incurred – and more time will pass – as the campaign to get the necessary approvals continues.

Polymetal International [LSE: POLY]

Precious metals mining company Polymetal has released full year results this morning, but investors may well find themselves disappointed with the numbers. Earnings per share fell short of expectations a year ago and that has been repeated again today. Headline income was up notably, but rising costs and the impact of a stronger Russian Rouble – the company does a lot of mining in the country – took their toll.  A 5% increase in the dividend is being proposed in a bid to keep shareholders onside as many of the extra costs are seen as being one-off payments.

Like this article? Sign up to our free newsletter.

This article does not constitute investment advice. Do your own research or consult a professional advisor.

The Armchair Trader's 'How to' Guides

In-depth Reports

Detailed reviews of selected companies and investment trusts.

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
FP Markets
IG
Pepperstone
WisdomTree
CME Group
Back To Top